Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
Expression of a dopamine D2 receptor-activated K+ channel on identified striatopallidal and striatonigral neuronsB L Waszczak, L P Martin, G J Greif, et al.Journal of Theoretical Biology|November 18, 2024
Enlightening the blind spot of the Michaelis-Menten rate law: The role of relaxation dynamics in molecular complex formationJunghun Chae, Roktaek Lim, Thomas L P Martin, et al.Plos Computational Biology|December 11, 2023
Generalized Michaelis-Menten rate law with time-varying molecular concentrationsRoktaek Lim, Thomas L P Martin, Junghun Chae, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1990
Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptineD M Jackson, L P Martin, L G Larsson, et al.Scientific Data|August 14, 2020
Publisher Correction: Large-scale metabolic interaction network of the mouse and human gut microbiotaRoktaek Lim, Josephine Jill T Cabatbat, Thomas L P Martin, et al.Scientific Data|June 28, 2020
Large-scale metabolic interaction network of the mouse and human gut microbiotaRoktaek Lim, Josephine Jill T Cabatbat, Thomas L P Martin, et al.Gynecologic Oncology|December 6, 2011
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II ConsortiaH J Mackay, R J Buckanovich, H Hirte, et al.Investigational New Drugs|January 28, 2014
Phase II trial of vorinostat in advanced melanomaN B Haas, I Quirt, S Hotte, et al.British Journal of Cancer|September 22, 2012
Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumoursL P Martin, M F Kozloff, R S Herbst, et al.British Journal of Cancer|September 20, 2012
Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumoursM F Kozloff, L P Martin, M Krzakowski, et al.Pageof 6